Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

ASRT Stock Summary

• Over the past twelve months, ASRT has reported earnings growth of -132.67%, putting it ahead of merely 14.2% of US stocks in our set.
• In terms of volatility of its share price, ASRT is more volatile than 93.27% of stocks we're observing.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ASRT comes in at -29.1% -- higher than that of only 13.58% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Assertio Holdings Inc, a group of peers worth examining would be WRLD, EEX, AP, BRP, and ACEL.
• ASRT's SEC filings can be seen here. And to visit Assertio Holdings Inc's official web site, go to www.assertiotx.com.

ASRT Valuation Summary

• In comparison to the median Healthcare stock, ASRT's EV/EBIT ratio is 105.8% lower, now standing at -1.7.
• Over the past 243 months, ASRT's price/earnings ratio has gone up 3.6.
• Over the past 243 months, ASRT's EV/EBIT ratio has gone up 3.

Below are key valuation metrics over time for ASRT.

ASRT Growth Metrics

The year over year cash and equivalents growth rate now stands at -42.41%.
• Its 2 year revenue growth rate is now at -54.02%.
• Its 3 year cash and equivalents growth rate is now at -39.72%.

Over the past 70 months, ASRT's revenue has gone down $304,297,000.

The table below shows ASRT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	111.014	5.523	-1.281
2021-09-30	107.86	-4.59	-30.241
2021-06-30	116.953	-23.675	-44.5
2021-03-31	112.197	-44.735	-64.83
2020-12-31	106.275	-65.572	-28.144
2020-09-30	135.325	-51.735	-196.417

ASRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ASRT has a Quality Grade of C, ranking ahead of 35.61% of graded US stocks.
• ASRT's asset turnover comes in at 0.367 -- ranking 129th of 680 Pharmaceutical Products stocks.
• NOVN, ARWR, and RIOT are the stocks whose asset turnover ratios are most correlated with ASRT.

The table below shows ASRT's key quality metrics over time.